Safety

Oncology·MeSH: Colorectal Neoplasms

21 drugs in development·18 companies·2 clinical trials

Drug Pipeline by Phase

Approved(16)

Drug	Company
butalbital	LANNETT CO INC (LCI)
butalbital	QIAGEN N.V. (QGEN)
butalbital	Optec International, Inc. (GM)
cayston	GILEAD SCIENCES, INC. (GILD)
chenodiol	Optec International, Inc. (GM)
emblaveo	AbbVie Inc. (ABBV)
gloperba	SCILEX HOLDING CO (SCLX)
hp+detect™	BIOMERICA INC (BMRA)
lamotrigine	Teva Pharmaceutical Industries Limited (TEVA)
mesalamine	Amneal Pharmaceuticals, Inc. (AMRX)
nexobrid	MediWound Ltd. (MDWD)
promacta	Novartis AG (NVS)
tobi podhaler	Viatris Inc (VTRS)
ursodiol	Optec International, Inc. (GM)
veregen	ANI PHARMACEUTICALS INC (ANIP)
zoledronic acid	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(1)

Drug	Company
surzebiclimab	BeOne Medicines Ltd. (ONC)

Phase 1(1)

Drug	Company
ALPHA-1062 original nasal formulation (Phase I studies)	Alpha Cognition Inc. (ACOG)

Unknown(3)

Drug	Company
brilaroxazine	REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
The Satchel™	American Cannabis Company, Inc. (AMMJ)
VOC platform (NISD co-development)	Ainos Inc. (AIMD)

BioSniper tracks 21 drugs in development for Safety across 18 companies.

There are 2 clinical trials targeting Safety tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.